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Abstract: Anaphylaxis is an increasing problem in public health. Th e food allergens (mainly milk, eggs, 
and peanuts) are the most frequent cause of anaphylaxis in children and youth. In order to defi ne the 
cause of anaphylaxis, skin tests, the determination of the concentration of specifi c IgE in the blood and 
basophil activation test are conducted. In vitro tests are preferred due to the risk of allergic response dur-
ing in vivo tests. Component-resolved diagnosis (CRD) is an additional tool in allergology, recommended 
in the third level of diagnostics when there are diagnostic doubts aft er the above mentioned tests have 
been carried out. 
Th e paper presents 3 cases of patients with anaphylactic response, and the application of CRD in these 
patients helped in planning the treatment. Patient 1 is a 4-year-old boy with diagnosed atopic dermatitis 
and bronchial asthma reported an anaphylactic shock at the age of seven months caused by cow’s milk 
and the exacerbation of bronchial asthma aft er eating some fruit. Patient 2 is a 35-year-old woman who 
has had anaphylactic shock three times: in June 2015, 2016, and 2017 and associates these episodes with 
the consumption of dumplings with a caramel, bun, and the last episode took place during physical exer-
tion few hours aft er eating waffl  e. Patient 3 is a 26-year-old man with one-time loss of consciousness aft er 
eating mixed nuts and drinking beer.
CRD off ers the possibility to conduct a detailed diagnostic evaluation of patients with a history of ana-
phylactic reaction.
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Introduction
Anaphylaxis is defi ned as severe, life-threatening generalized or systemic oversensitivity 
that can occur in the immunological mechanism (IgE-dependent or IgE-independent) 
or not related to the immunological system (non-allergic anaphylaxis) [1].
It goes without saying that anaphylaxis is an increasing problem in public health. 
Due to the complexity of the clinical picture, gathering of fully reliable epidemiological 
data is diffi  cult. It is reported that anaphylaxis occurs in adults in Europe with the 
frequency of 1.5–7.9:100,000 man-years, while this ratio fluctuates in children, 
depending on the data sources, from 0.19:100,000 up to the ratio occurring in 
adults  [2]. In Poland in 2015, 3144 people received treatment for anaphylactic shock 
with an estimated prevalence rate of anaphylaxis of 8.2 per 100,000 (8.4 for females and 
7.9 for males) [3]. Th e number of anaphylaxis cases has increased in the last decade, 
with the increase of food anaphylaxis at even 350%, and anaphylaxis induced by other 
factors grew by 230%. Th e number of anaphylaxis-related hospital admissions has also 
increased [4]. Th e annual mortality rate is 1–3 persons per one million. Bronchospasm 
is the main cause of anaphylaxis related mortality (96% of cases) [5].
Th e  food allergens (mainly milk, eggs, and peanuts) are the most frequent cause 
of anaphylaxis in children and youth. In adults, it is venoms of Hymenoptera and 
medications (mainly antibiotics) prevail among other allergens. Approximately 20% of 
anaphylaxis cases have an unknown origin (the so-called idiopathic anaphylaxis) [5].
Regardless of the route of stimulating mastocytes and basophils, the anaphylaxis 
mechanism includes the releasing of a  number of biologically active factors; the 
so-called preformed mediators, i.e. histamine, tryptase, heparin, and chymase, 
released within 5–15 minutes. Then, de novo synthesized mediators, which are 
platelet-activating factor (PAF), leukotrienes, and prostaglandins, are released within 
10–30 minutes. It should be noted that in 20% of cases the anaphylaxis takes place in 
two stages, with the delayed response within 4–12 hours, and among others, cytokines 
and chemokines are responsible for the occurrence of anaphylaxis [6].
Clinically, anaphylaxis manifests itself in a  severe response that mainly aff ects the 
skin, the respiratory, and/or cardiovascular systems. Food allergens most frequently 
induce symptoms in the respiratory system, and insect venoms induce the response of 
the cardiovascular system, while medications cause skin lesions. Currently, there are 
3 groups of anaphylaxis criteria that are presented in Table 1 [1]. Anaphylaxis comes on 
in several tens of minutes aft er the contact with the allergen, and references cite medians 
of response time aft er 5, 15, and 30 minutes, which corresponds to response elicited 
by medications administered parenterally, insect venoms, and foods. Left  untreated, the 
response progresses fast and may cause death [7]. Aft er the anaphylactic response, the 
patient should be monitored for 8–24 hours, because the symptoms of the response can 
be delayed and such symptoms can be more severe than previous ones [8].
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Table 1. Criteria for diagnosing anaphylaxis. 
1. A sudden onset the disease (from several minutes to several hours) associated by lesions of the 
skin and/or mucous membranes (e.g. systemic urticaria, pruritus, itching, erythema, swelling) 
and symptoms in at least one of the following systems: 
a) Respiratory tract (e.g. shortness of breath, bronchospasm, stridor, hypoxia)
b) Cardiovascular system (e.g. blood pressure drop, fainting)
2. Symptoms of two or more following systems which occur soon aft er the fi rst systems (from several 
minutes to several hours) aft er exposure to the probable allergen in specifi c patients: 
a) Skin / mucous membranes (e.g. generalized urticaria, itching or erythema, swelling)
b) Respiratory tract (e.g. shortness of breath, bronchospasm, stridor, hypoxia)
c) Cardiovascular system (e.g. blood pressure drop, fainting)
d) Alimentary tract (e.g. stomach cramps, vomiting)
3. Hypotension aft er the exposure to a  known allergen aff ecting the specifi c patient (from several 
minutes to several hours):
a) Infants and children — low arterial systolic pressure or a drop in the systolic pressure o >30%
b) Adults — arterial systolic pressure <90 mm Hg or a  drop in the systolic pressure >30% in 
comparison to the initial value
Asthma predisposes to a  more severe progress of anaphylaxis, especially caused 
by food. Other risk factors for the severe systemic response are co-existing diseases 
such as mastocytosis, deficiency of platelet-activating factor acetylhydrolase, and 
cardiovascular diseases, especially those that require administration of β-blockers, 
angiotensin-converting-enzyme inhibitors, and anaphylaxis in the medical history. 
Th e main cofactors for anaphylaxis include alcohol, physical exercise, severe infections, 
premenstrual period, or stress [9].
Past mild or moderate response does not preclude subsequent severe episodes in 
the future. Th at is why aft er each anaphylaxis incident, regardless of its severity, the 
patient must be supplied with a  rescue drug kit (epinephrine in a pre-fi lled syringe, 
antihistamine, and glucocorticoid administered orally) [10].
Diagnosing anaphylaxis is confi rmed by the increased tryptase concentration 
in the blood (optimal testing time 15–180 minutes following the response to the 
inducing factor) or histamine (optimal testing time 15–60 minutes). Th e  procedure 
applied in the allergic outpatient clinic includes gathering medical history and the 
identifi cation of the inducing factor using additional tests that should be carried out 
no earlier than aft er 3–4 weeks following the anaphylactic response, optimally up to 
1 year. In order to defi ne the cause of anaphylaxis, skin prick tests (SPT), intradermal 
test (IDT), prick by prick tests, the determination of the concentration of specifi c IgE 
(sIgE) in the blood and basophil activation test (BAT) are conducted. In vitro tests are 
preferred due to the risk of allergic response during in vivo tests [6].
Component-resolved diagnosis (CRD) is an additional tool in allergology, 
recommended in the third level of diagnostics when there are diagnostic doubts 
aft er the above mentioned tests have been carried out. CRD is especially useful in 
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the allergic response to food, because the detection of sensitising molecules provides 
information on the severity of the allergy and potential cross reactions [11].
Milk, eggs, and peanuts
Cow’s milk protein (CMP) is the most frequent cause of food allergy in children, and it 
occurs in 1–3% of the youngest population. Most of this population becomes tolerant 
by the age of 5, but, at present, the age of becoming tolerant has been increasing, even 
up to 16–17 years [12]. Allergy to cow’s milk protein in adults can remain aft er the 
childhood or start at an older age, which applies to 0.1–0.5%. CMP are responsible 
for 13% of all fatal anaphylactic responses caused by food allergens [13].
Cow’s milk contains about 30–35 g of proteins per litre, and it consists of two 
fractions: curd (coagulum) — 80%, and whey (lactoserum) — 20% [14]. Th e  main 
allergens are caseins, alpha-lactoglobulin, and beta-lactoglobulin, and most patients 
are hypersensitive to several various proteins [15].
Th e  application of CRD in an allergy to CMP is helpful in the risk assessment 
of severe responses to unprocessed milk and thermally treated milk. CMP belong 
to class I  of food allergens due to its resistance to heat. Th e  casein fraction is very 
resistant to high temperatures, and the bond with IgE is strong aft er 90 minutes of 
boiling at a temperature above 90°C. Due to the above, the high concentration of sIgE 
against Bos d 8 is connected with the sensitivity to milk, even in the baked form. 
Whey fraction is more sensitive to thermal treatment than caseins, and the bond with 
IgE is broken down aft er 15–20 minutes of heating above 90°C (Table 2) [11].
Table 2. Allergens in the cow milk, hen egg, peanuts, heat stability taken into account.
Cow’s milk allergens
Curd (coagulum)
Bos d 8 (Caseins)*, Bos d 9 (AlphaS1-casein)*, Bos d 10 (AlphaS2-casein)*, Bos 
d 11 (Beta-casein)*, Bos d 12 (Kappa-casein)*
Cow’s milk allergens
Whey (lactoserum)
Bos d 4 (Alpha-lactalbumin), Bos d 5 (Beta-lactoglobulin), Bos d 6 (Bovine 
serum albumin), Bos d 7 (Immunoglobulins), Bos d LF (Lactoferrin)
Egg white allergens Gal d 1 (Ovomucoid)*, Gal d 2 (Ovalbumin), Gal d 3 (Ovotransferin/conalbu-
min), Gal d 4 (Egg lysozyme)
Egg yolk allergens Gal d 5 (Phosvitin/α-livetin), Gal d 6 (Apovitellenins I), Apovitellenins VI/apo-
protein B)
Peanut allergens Ara h 1 (Cupin/vicilin-type,7S globulin)*, Ara h 2 (Conglutin, 2S albumin)*, 
Ara h 3 (Cupin, 11S globulin)*, Ara h 5 (Profi lin), Ara h 6 (Conglutin, 
2S albumin)*, Ara h 7 (Conglutin, 2S albumin)*, Ara h 8 (Pathogenesis-related 
protein), Ara h 9 (Non-specifi c lipid transfer protein type 1)*, Ara h 10 
(Oleosin)*, Ara h 11 (Oleosin)*, Ara h 12 (Defensins), Ara h 13 (Defensins), 
Ara h 14  (Oleosin)*, Ara h 15 (Oleosin)*, Ara h 16 (Non-specifi c Lipid Transfer 
Protein 2)*, Ara h 17 (Non-specifi c Lipid Transfer Protein 1)*
* Heat stability.
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CRD is signifi cant in the monitoring of the natural course of an allergy, in the 
evaluation of the probability for the acquisition of immunologic tolerance and 
the regression of symptoms. Th e  probability of “growing out” of the CMP allergy 
is higher in children with a  lower level of sIgE against milk, alpha-lactoglobulin, 
beta-lactoglobulin, and casein [16]. CRD determination can help in taking the decision 
on a  possible allergen challenge or immunotherapy/desensitization. Kuitunen et al. 
studied profi les of sIgE against milk proteins before and aft er oral immunotherapy 
(OIT) in 76 children between 5 and 17 years old. It was indicated that the high level 
of sIgE against alpha-lactoglobulin, beta-lactoglobulin, and casein was related to the 
lower probability of OIT success [17].
Th e occurrence of the rate of allergy to hen egg was estimated at 0.5–2.5% of the 
population. Its frequency ranks second in children suff ering from food allergies [13]. 
Th e  main allergens of the egg white include ovomucoid, ovalbumin, ovotransferin, 
lysozyme, and livetin (Table 2) [11]. 
The  resistance of specific proteins to denaturation is clinically significant, 
because the modifi cation of the allergen structure enables some patients to consume 
safely products with thermally treated eggs [11]. Ovalbumin and ovotransferin are 
thermolabile, and lysozyme is moderately resistant to heating, and the ovomucoid, the 
antigen mostly responsible for clinical symptoms of hypersensitivity, is thermostable. 
Th e determination of sIgE for thermosensitive ovalbumin helps in the diff erentiation 
of patients reacting to various forms (raw, baked) of eggs (Table 3) [18].
Table 3. Dependence between sIgE concentrations for molecules versus hen egg tolerance. 
Positive (low or medium) sIgE against egg white, negative or low sIgE against ovomucoid and 
ovalbumin → patients can consume eggs in any form.
Positive (low or medium) sIgE against egg white, negative or low against ovomucoid; positive sIgE 
against ovalbumin → patients do not tolerate raw eggs, but can consume boiled eggs.
Positive (medium or high) sIgE against egg white, increased sIgE against ovomucoid and ovalbumin 
→ patients are sensitive to eggs in any form.
Some studies show that the determination of sIgE to ovomucoid is signifi cant 
in the predication of the acquisition of tolerance to thermally treated eggs. Ando et 
al. found that in the case of the concentration of sIgE to ovomucoid amounting to 
10.8 kU/l, there is 95% allergy risk to boiled eggs [19]. In another, similar study, the 
cut-off  point was determined at 6.9 kU/l [20]. Patients with persistent allergy to eggs 
have a higher level of sIgE to ovomucoid and ovalbumin in comparison with children 
who tolerate eggs [18].
Jessadapakorn et al. conducted CRD of allergies to cow’s milk and egg white 
in Th ai children with symptoms of sensitivity in order to estimate the dependence 
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between the clinical symptoms and sensitising allergen, and sIgE against milk and egg 
white was measured. It was found that casein and beta-lactoglobulin are the most 
frequent milk allergens in studied children, while for eggs, these are ovomucoid and 
ovalbumin. In the case of allergy to milk, the concentration of sIgE against casein was 
higher in patients with urticaria compared to patients with atopic dermatitis. Patients 
with allergy to egg white, without atopic dermatitis (with symptoms related to the 
alimentary tract, urticaria, and anaphylaxis in medical history) presented higher 
concentrations of sIgE to ovomucoid in comparison to patients suff ering from atopic 
dermatitis [21].
Peanuts oft en cause a severe anaphylactic response to food, and the frequency of 
sensitization is estimated at 11% in children and 1–2% in adults [22, 23]. Th ey have 
a rich protein content (25% of the mass), which means a plethora of various potential 
allergens. In the component diagnostics for an allergy to peanuts, the content of sIgE 
to molecules Ara h 1–17 with various sensitising potential is determined (Table 2). 
Th ermostable allergens (Ara h 1, 2, 3, 6, 7) show the ability to induce more severe 
responses compared to thermolabile allergens [11].
Th e way of product preparation and processing [24] is signifi cant to the severity 
of anaphylaxis. The  most frequent form of peanut consumption, i.e. roasted, is 
connected with the intensifi ed Ara h 1 and 2 allergic potential, while the cooked 
peanuts consumed mainly in China have a decreased allergic potential [25, 26].
CRD application helps predict the level of response to peanuts and the effi  cacy 
of potential immunotherapy. The  double-blinded randomized study showed that 
Ara h 2 and Ara h 6 are good predictors of severe allergic symptoms [27]. Th e studies 
on the application of sublingual immunotherapy (SLIT) in an allergy to peanuts are 
underway. It was proved that patients with the initial low concentration of sIgE to 
Ara h 2, Ara h 3, and seed extract are relatively the most susceptible to desensitisation 
extract [28]. 
Nonspecifi c lipid transfer proteins 
Anaphylaxis has been associated with certain components, such as seed storage proteins 
(2S albumins, 7S vicilins, and 11S legumines) or nonspecifi c lipid transfer proteins 
(nsLTPs). International Union of Immunological Societies Allergen Nomenclature 
Sub-Committee cites the list of 41 sensitizing nsLTPs, which derive from fruit, tree 
and grass pollens, vegetables, peanuts, and natural latex. One of the fi rst described 
proteins was molecule Pru p 3 found in peaches. Its structure and composition 
imposes resistance to temperature and pH changes, which means that this protein 
remains unchanged in the human organism. Th ree main epitopes binding sIgE were 
identifi ed, and they are considerably similar to proteins of other plants (e.g., apple, 
apricot, cherry, strawberry, grape and plum), which indicates the possibility of the 
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occurrence of cross responses dependent on the similarity level. Symptoms of nsLTP 
hipersensitivity include the following: oral allergy syndrome (OAS), nausea, vomiting, 
diarrhoea, urticaria, exacerbation of asthma and anaphylactic response [11, 29].
nsLTP are also described as a  risk factor of anaphylaxis induced by physical 
exercise (food-dependent exercise-induced anaphylaxis, FDEIA) [30]. Calvani et 
al. report a  case of a  patient with FDEIA in their medical history who consumed 
products containing popular allergens such as milk, eggs, cacao, and peanuts before 
physical exercises, but the basic allergic tests showed negative results. Molecular 
diagnostics revealed the presence of sIgE against Pru p 3 [31]. Avoiding consumption 
of food that are related to FDEIA before exercise prevents subsequent episodes of 
anaphylaxis [32, 33].
The  paper presents 3 cases of patients with anaphylactic response, and the 
application of CRD in these patients helped in planning the treatment.
Patient 1
A 4-year-old boy with diagnosed atopic dermatitis and bronchial asthma reported 
an anaphylactic shock at the age of seven months caused by cow’s milk and the 
exacerbation of bronchial asthma aft er eating some fruit. Th e  sIgE panel revealed 
positive results for a dozen or so of foods, and the boy was administered a  restrictive 
diet on this basis (Table 4). Th e diagnostics was extended by a determination of allergic 
components (ImmunoCAP ISAC sIgE) to verify the tests. Positive results for main
Table 4. Results of sIgE laboratory tests and dietary recommendation for patient 1.
Food panel 
(sIgE against 
extracts)
hazelnut (103 kU/l, Class 6), peanuts (300 kU/l, Class 6), walnut (21 kU/l, Class 4), 
almond (59 kU/l, Class 5), milk (581 kU/l, Class 6), casein (490 kU/l, Class 6), egg 
white (5 kU/l, Class 3), egg yolk (11 kU/l, Class 3), celery (234 kU/l, Class 6), carrot 
(221 kU/l, Class 6), tomato (101 kU/l, Class 6), cod (3,6 kU/l, Class 3), peach (311 
kU/l, Class 6), apple 281 kU/l (Class 6), soya 127 kU/l (Class 6), wheat fl our (182 kU/l, 
Class 6), sesame (222 kU/l, Class 6), rye fl our (35 kU/l, Class 4)
Diet on the 
basis of the 
food panel 
Forbidden consumption for: milk, eggs (in any form), nuts, almonds, fruit (peach, 
apple), vegetables (potato, celery, carrot, tomato), cod, soy, wheat and rye fl ours, 
sesame. 
CRD 
(IgE Multiplex 
FABER)
alpha-lactoglobulin (Bos d 4): 85 ISU-E, beta-lactoglobulin (Bos d 5): 31 ISU-E, 
casein (Bos d 8): 48 ISU-E); 
walnut (7S globulin (Jug r 2, storage protein): 17 ISU-E), soy (glycinin (Gly m 6, 
storage protein): 6,1 ISU-E)
hazelnut (Cor a 1.0401): 15 ISU-E, apple (Mal d 1): 21 ISU-E, peach (Pru p 1): 18 ISU-E
Diet on the 
basis of CRD
Complete ban on consumption of cow milk including products thermally treated, 
walnut, soy. Cautious consumption of fresh fruit, vegetables and nuts. 
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allergic components of milk, walnut, and soya were found (Table 4). Th ere were also 
positive results for the main components of birch inhaled allergens (Bet v 1): 27 ISU-E 
and grass allergens (Phl p 1: 116 ISU-E, Phl p 2: 3,3 ISU-E, Phl p 5: 132 ISU-E). 
Comment
Patient 1 should be recommended a  restrictive diet without cow’s milk and derived 
foods, including thermally treated products. Due to the high concentration of milk 
components (Bos d 8: 48 ISU-E, Bos d 4: 85 ISU-E, Bos d 5: 31 ISU-E) oral allergen 
challenge is not recommended although 3 years elapsed aft er the anaphylactic shock. 
Th e presence of the above mentioned molecules shows a high risk of surviving cow’s 
milk allergy. Th ere were negative results of tests for the main protein components 
(Gal d 1, Gal d 2, Gal d 3) and yolk (Gal d 5), which enabled adding eggs to the 
recommended diet. Reported symptoms of bronchial asthma aft er fresh fruit can 
be caused by components from Pathogenesis-related (PR-10) family. Due to the 
presence of Bet v 1, Phl p 1, Phl p 2, Phl p 5 components, the probability of successful 
immunotherapy with specifi c birch and grass allergens is high. 
Patient 2
A 35-year-old woman has been a patient of the Center of Clinical and Environmental 
Allergology of the University Hospital in Krakow since June 2012 due to atopic 
dermatitis (AD). She has suff ered from AD since early childhood. Th ere is no data 
on CMP allergy in her medical history. She reports rhinitis without dyspnoea in the 
autumn-winter season. She underwent house dust mite immunotherapy in  1995–1998 
with partial relief of symptoms. Th e family history for atopy is positive, and her mother 
and her brother have AD. Th e results of additional tests performed in the clinic were as 
follows: concentration of total IgE 3429 IU/ml, sIgE egg white: 0.73  kUA/l    (Class  2), 
sIgE egg yolk: 0.34 kUA/l (Class 0), sIgE milk: 34.4  kUA/l (Class  4), sIgE 
Dermatophagoides pteronyssinus >100 kUA/l (Class 6), sIgE Dermatophagoides 
fararinae >100 kUA/l (Class 6), sIgE cat: 80.2 kUA/l (Class 5). A dairy-free diet, an oral 
antihistaminic drug, and local treatment (emollient, corticosteroids, and calcineurin 
inhibitor) has been ordered.
The  patient has remained in periodic control in the clinic. Even though the 
condition of the skin improved due to the introduced diet, she has had periodic 
exacerbations, including those requiring hospitalization in the Dermatological Clinic. 
She has introduced products containing processed goat milk into her diet without any 
consultations, with good tolerance and without aff ecting skin lesions as she has claimed.
Th e  patient has had anaphylactic shock three times: June 2015, 2016, and 2017. 
Th e  symptoms were as follows: utricaria, dyspnea, abdominal pain, and vomiting. 
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She associates these episodes with the consumption of dumplings with a  caramel, 
bun, and the last episode took place during physical exertion few hours aft er eating 
waffl  e. Th e results of repeated additional tests were as follows: sIgE milk: Class 6, sIgE 
casein: Class 6, sIgE egg white: Class 6, sIgE egg yolk: Class 2, sIgE fl our: Class 0, 
sIgE Dermatophafoides pteronyssinus: Class 6, sIgE cat: Class 6.
Th e  diagnostics has been extended to the determination of the allergens’ compo-
nents (IgE Multiplex FABER). Positive components among food allergens were as follows: 
Bos d 8: 133.54 FIU/ml; Gal d 1: 10.61 FIU/ml, Gal d 2: 13.52 FIU/ml, Gal d 3: 1.61 FIU/ml, 
and Gal d 4: 4.69 FIU/ml. Positive components among respiratory allergens were positive 
for house dust mites and cats, as follows: Der  f 1: 7.3 FIU/ml, Der f 2: 123.19   FIU/ml, 
Der p 1: 18.06 FIU/ml, Der p 2: 147.01 FIU/ml, and Fel d 1: 105.05 FIU/ml.
Comment 
Patient 2 must undergo a  restrictive diet without cow’s milk and its derivatives, 
including thermally treated products. Due to the high concentration of sIgE against 
Bos d 8, desensitization to cow’s milk was not attempted.
Th ere is a 90% homology in the amino acid sequence between cow’s milk casein 
and casein of milk from other mammals, e.g., sheep or goats. It is a cause of frequent 
cross reactivity [14]. Despite a  high concentration of sIgE against Bos d  8, the 
patient could eat goat’s milk without allergic symptoms. It can be attributed to the 
lower casein content in goat’s milk. Th ere are reports on allergies to casein present 
in milk of a  single animal species [34–36]. Besu et al. studied concentrations of 
sIgE against goat milk proteins in patients suff ering from recurrent aphthous ulcers 
associated with allergies to CMP. It was observed that the levels of sIgE against 
goat’s milk were signifi cantly lower than sIgE against CMP. It indicates a possibility 
of the safe consumption of goat’s milk by some patients with CMP allergy [37]. 
Th e determination of a high concentration of sIgE against Gal d 1 implies applying 
an egg-free diet, even if eggs are thermally treated. Due to continued symptoms of 
allergic rhinitis and the concentration of Der f 1: 7.3 FIU/ml, Der f 2: 123.19 FIU/ml, 
Der p 1: 18.06 FIU/ml, Der p 2: 147.01 FIU/ml a  specifi c immunotherapy against 
dust mite allergens is recommended. 
Patient 3
A 26-year-old man was consulted at the Center of Clinical and Environmental 
Allergology of the University Hospital in Krakow due to a  one-time loss of 
consciousness aft er eating mixed nuts and drinking beer. He reported chronic rhinitis 
with no concomitant skin lesions or dyspnoea. Th e patient did not remember his last 
consumption of nuts, and he did not recall any symptoms aft er eating his normal 
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diet. He denied taking medicines or receiving any kind of chronic treatment. SPT 
of inhalant allergens was positive for grass, rye, birch, fi lbert, alder, and timothy. 
Th e  concentrations of sIgE were very high for peanut, sesame, citrus fruit, celery, 
peach, tomato (Class 6).
Th e  diagnostics has been extended to determination of allergens’ components 
(IgE Multiplex FABER). The  results of allergen-specific IgE serum testing were 
positive for the peanut extract (Ara h: 4.83 FIU/ml) but negative for all of 
the main peanut molecules (Ara h 1-NT, Ara h 2, Ara h 3, Ara h 6, Ara h 8, 
Ara  h  9, Ara  h Agglutinin). Increased levels of sIgE were measured against nsLTP 
molecules of walnut (Jug  r 3; 0.58 FIU/ml), peach (Pru p 3; 2.13 FIU/ml), hazelnut 
(Cor a  8; 4.33  FIU/ml), pomegranate (Pun g 1; 1.5 FIU/ml), and maze (Zea m 14; 
1.17 FIU/ml).
Comment 
In Patient 3, a  positive result of sIgE for peanut extract was obtained, while sIgE 
for the determined allergen components (Aha h 1, Ara h 2, Ara h 3, Ara h 6, Ara 
h 8.0101, Ara h 9, Ara h Agglutinin) were not present. Th e  positive result for sIgE 
related to the extract could be caused by a cross reaction with inhaled allergens or an 
allergy to a molecule not determined in the conducted tests [11].
During the medical interview, our patient mentioned the consumption of 
alcoholic drinks which could contribute to the occurrence of response to nut mixture. 
Th e European Anaphylaxis Registry reports that alcohol can be a cofactor of as many 
as 15% of responses [38].
Detection of sIgE against nsLTP present in peach (Pru p 3), hazelnut (Cor a 8), 
walnut (Jug r 3), grenade fruit (Pun g 1), and maze (Zea m 14) enabled a  precise 
formulation of dietary recommendations. Th e  patient must avoid food containing 
nsLTP, especially in the presence of anaphylaxis cofactors. 
Summary
CRD is a  new diagnostic method that employs the determination of sIgE against 
specifi c allergen molecules, thus increasing the specifi city of the test [39]. In this way, 
dietary recommendations can be verifi ed that are very signifi cant in the context of 
indications found during medical interviews for patients with anaphylactic shock. 
Th e diet should eliminate potentially dangerous foods, but it should also maintain the 
patients’ life quality to the maximum extent [40]. 
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